HAEMOPHILUS INFLUENZAE TYPE B
UNII F2TW0N64FI

Substance Identification & Data

This profile provides standardized clinical and technical data for Haemophilus Influenzae Type B, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F2TW0N64FI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 50937. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F2TW0N64FI

CAS Registry Number

N/A

RxNorm Concept ID

50937

Detailed Substance Profile

Preferred Name

HAEMOPHILUS INFLUENZAE TYPE B

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

F2TW0N64FI

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C75787

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

962062

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

727

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Haemophilus Influenzae Type B. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.